Latest News about MRNA
Recent news which mentions MRNA
Everything you need to know about what it would take for the FDA to approve a COVID-19 vaccine
Today 17:19 EDT
From MarketWatch
Scientists examine how adults and children fight off COVID-19 — and say it may have implications for vaccine research
Today 5:51 EDT
From MarketWatch
Inovio Defies Market-Wide Weakness: What's Behind The Rally?
September 21, 2020
From Benzinga
'Too Early For Victory Laps': Stock Market Update For The Week Ahead
September 20, 2020
From Benzinga
3 Moderna Analyst Takes On The Coronavirus Vaccine Developer's Pipeline
September 18, 2020
Tickers
MRNA
From Benzinga
Dr. Fauci: ‘We may be able to put this coronavirus outbreak behind us’ — but says the American public must play a critical role
September 18, 2020
From MarketWatch
Is AstraZeneca Still A Safe Bet?
September 17, 2020
From Benzinga
7 Reasons Why A Coronavirus Vaccine May Not Work The Way You Hope
September 17, 2020
From Benzinga
Dr. Offit: Prepare to wear masks and socially distance even after getting COVID-19 vaccine
September 17, 2020
From MarketWatch
Coronavirus update: Global cases near 30 million; Trump contradicts CDC head on vaccine timetable and again derides face masks
September 17, 2020
From MarketWatch
COVID-19 Vaccine Developer Moderna In The Spotlight With R&D Day, 2 Collaborations
September 17, 2020
Tickers
MRNA
From Benzinga
A handful of wealthy countries own more than half of the world’s COVID-19 vaccine supply, warns Oxfam
September 17, 2020
From MarketWatch
The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO
September 17, 2020
From Benzinga
A Peek Into The Markets: US Stock Futures Tumble Ahead Of Initial Jobless Claims Data
September 17, 2020
From Benzinga
5 Stocks To Watch For September 17, 2020
September 17, 2020
From Benzinga
Sinovac Plans To Expand COVID-19 Vaccine Trials To Children And Adolescents
September 17, 2020
From Benzinga
AstraZeneca Trial Participant Adverse Events Likely Unrelated To COVID-19 Vaccine: Oxford
September 16, 2020
From Benzinga
AstraZeneca Gets India Go-Ahead To Resume COVID-19 Vaccine Trials, US Nod Awaited
September 16, 2020
From Benzinga
What's Significant About Moderna's Expansion Outside North America
September 16, 2020
From Benzinga
The Daily Biotech Pulse: Moderna Expands Into Switzerland, Tiziana To Spin Off Testing Unit, Metacrine IPO
September 16, 2020
From Benzinga
We The (Indebted) People
September 14, 2020
From Benzinga
Moderna's Late-Stage Coronavirus Vaccine Study Hits 78% Enrollment
September 14, 2020
From Benzinga
AstraZeneca Shows the Risk of Investing in Coronavirus Vaccine Stocks
September 14, 2020
From Motley Fool
Merck (Finally) Starts a Clinical Trial of its Coronavirus Vaccine
September 13, 2020
From Motley Fool
Pfizer Seeks FDA Nod To Expand Late-Stage COVID-19 Vaccine Trial
September 13, 2020
From Benzinga
Pfizer and BioNTech Plan to Increase Size of Their Coronavirus Vaccine Clinical Trial
September 13, 2020
From Motley Fool
Moderna Slowed Enrollment in Its Phase 3 Coronavirus Vaccine Clinical Trial
September 13, 2020
From Motley Fool
The Surefire Vaccine Winner Following AstraZeneca's COVID-19 Trial Pause
September 13, 2020
From Motley Fool
What If More Than One Company Wins the Coronavirus Vaccine Race?
September 13, 2020
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.